img

Global Brand Drugs Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Brand Drugs Market Research Report 2024

A medication (also referred to as medicine, pharmaceutical drug, or simply drug) is a drug used to diagnose, cure, treat, or prevent disease. Drug therapy (pharmacotherapy) is an important part of the medical field and relies on the science of pharmacology for continual advancement and on pharmacy for appropriate management.
According to Mr Accuracy reports new survey, global Brand Drugs market is projected to reach US$ 1507000 million in 2029, increasing from US$ 1071000 million in 2022, with the CAGR of 5.0% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Brand Drugs market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Brand Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Pfizer
Roche
Sanofi
Johnson & Johnson
Merck & Co. (MSD)
Novartis
AbbVie
Gilead Sciences
GlaxoSmithKline (GSK)
Amgen
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
Teva
Bayer
Novo Nordisk
AbbVie
Takeda
Boehringer Ingelheim
Takeda
Segment by Type
Biopharmaceutical
Chemistry Medicine

Segment by Application


Hospital
Clinic
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Brand Drugs report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Brand Drugs Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Biopharmaceutical
1.2.3 Chemistry Medicine
1.3 Market by Application
1.3.1 Global Brand Drugs Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Brand Drugs Market Perspective (2018-2029)
2.2 Brand Drugs Growth Trends by Region
2.2.1 Global Brand Drugs Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Brand Drugs Historic Market Size by Region (2018-2024)
2.2.3 Brand Drugs Forecasted Market Size by Region (2024-2029)
2.3 Brand Drugs Market Dynamics
2.3.1 Brand Drugs Industry Trends
2.3.2 Brand Drugs Market Drivers
2.3.3 Brand Drugs Market Challenges
2.3.4 Brand Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Brand Drugs Players by Revenue
3.1.1 Global Top Brand Drugs Players by Revenue (2018-2024)
3.1.2 Global Brand Drugs Revenue Market Share by Players (2018-2024)
3.2 Global Brand Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Brand Drugs Revenue
3.4 Global Brand Drugs Market Concentration Ratio
3.4.1 Global Brand Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Brand Drugs Revenue in 2022
3.5 Brand Drugs Key Players Head office and Area Served
3.6 Key Players Brand Drugs Product Solution and Service
3.7 Date of Enter into Brand Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Brand Drugs Breakdown Data by Type
4.1 Global Brand Drugs Historic Market Size by Type (2018-2024)
4.2 Global Brand Drugs Forecasted Market Size by Type (2024-2029)
5 Brand Drugs Breakdown Data by Application
5.1 Global Brand Drugs Historic Market Size by Application (2018-2024)
5.2 Global Brand Drugs Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Brand Drugs Market Size (2018-2029)
6.2 North America Brand Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Brand Drugs Market Size by Country (2018-2024)
6.4 North America Brand Drugs Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Brand Drugs Market Size (2018-2029)
7.2 Europe Brand Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Brand Drugs Market Size by Country (2018-2024)
7.4 Europe Brand Drugs Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Brand Drugs Market Size (2018-2029)
8.2 Asia-Pacific Brand Drugs Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Brand Drugs Market Size by Region (2018-2024)
8.4 Asia-Pacific Brand Drugs Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Brand Drugs Market Size (2018-2029)
9.2 Latin America Brand Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Brand Drugs Market Size by Country (2018-2024)
9.4 Latin America Brand Drugs Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Brand Drugs Market Size (2018-2029)
10.2 Middle East & Africa Brand Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Brand Drugs Market Size by Country (2018-2024)
10.4 Middle East & Africa Brand Drugs Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Brand Drugs Introduction
11.1.4 Pfizer Revenue in Brand Drugs Business (2018-2024)
11.1.5 Pfizer Recent Development
11.2 Roche
11.2.1 Roche Company Detail
11.2.2 Roche Business Overview
11.2.3 Roche Brand Drugs Introduction
11.2.4 Roche Revenue in Brand Drugs Business (2018-2024)
11.2.5 Roche Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Detail
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Brand Drugs Introduction
11.3.4 Sanofi Revenue in Brand Drugs Business (2018-2024)
11.3.5 Sanofi Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Detail
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Brand Drugs Introduction
11.4.4 Johnson & Johnson Revenue in Brand Drugs Business (2018-2024)
11.4.5 Johnson & Johnson Recent Development
11.5 Merck & Co. (MSD)
11.5.1 Merck & Co. (MSD) Company Detail
11.5.2 Merck & Co. (MSD) Business Overview
11.5.3 Merck & Co. (MSD) Brand Drugs Introduction
11.5.4 Merck & Co. (MSD) Revenue in Brand Drugs Business (2018-2024)
11.5.5 Merck & Co. (MSD) Recent Development
11.6 Novartis
11.6.1 Novartis Company Detail
11.6.2 Novartis Business Overview
11.6.3 Novartis Brand Drugs Introduction
11.6.4 Novartis Revenue in Brand Drugs Business (2018-2024)
11.6.5 Novartis Recent Development
11.7 AbbVie
11.7.1 AbbVie Company Detail
11.7.2 AbbVie Business Overview
11.7.3 AbbVie Brand Drugs Introduction
11.7.4 AbbVie Revenue in Brand Drugs Business (2018-2024)
11.7.5 AbbVie Recent Development
11.8 Gilead Sciences
11.8.1 Gilead Sciences Company Detail
11.8.2 Gilead Sciences Business Overview
11.8.3 Gilead Sciences Brand Drugs Introduction
11.8.4 Gilead Sciences Revenue in Brand Drugs Business (2018-2024)
11.8.5 Gilead Sciences Recent Development
11.9 GlaxoSmithKline (GSK)
11.9.1 GlaxoSmithKline (GSK) Company Detail
11.9.2 GlaxoSmithKline (GSK) Business Overview
11.9.3 GlaxoSmithKline (GSK) Brand Drugs Introduction
11.9.4 GlaxoSmithKline (GSK) Revenue in Brand Drugs Business (2018-2024)
11.9.5 GlaxoSmithKline (GSK) Recent Development
11.10 Amgen
11.10.1 Amgen Company Detail
11.10.2 Amgen Business Overview
11.10.3 Amgen Brand Drugs Introduction
11.10.4 Amgen Revenue in Brand Drugs Business (2018-2024)
11.10.5 Amgen Recent Development
11.11 AstraZeneca
11.11.1 AstraZeneca Company Detail
11.11.2 AstraZeneca Business Overview
11.11.3 AstraZeneca Brand Drugs Introduction
11.11.4 AstraZeneca Revenue in Brand Drugs Business (2018-2024)
11.11.5 AstraZeneca Recent Development
11.12 Bristol-Myers Squibb
11.12.1 Bristol-Myers Squibb Company Detail
11.12.2 Bristol-Myers Squibb Business Overview
11.12.3 Bristol-Myers Squibb Brand Drugs Introduction
11.12.4 Bristol-Myers Squibb Revenue in Brand Drugs Business (2018-2024)
11.12.5 Bristol-Myers Squibb Recent Development
11.13 Eli Lilly
11.13.1 Eli Lilly Company Detail
11.13.2 Eli Lilly Business Overview
11.13.3 Eli Lilly Brand Drugs Introduction
11.13.4 Eli Lilly Revenue in Brand Drugs Business (2018-2024)
11.13.5 Eli Lilly Recent Development
11.14 Teva
11.14.1 Teva Company Detail
11.14.2 Teva Business Overview
11.14.3 Teva Brand Drugs Introduction
11.14.4 Teva Revenue in Brand Drugs Business (2018-2024)
11.14.5 Teva Recent Development
11.15 Bayer
11.15.1 Bayer Company Detail
11.15.2 Bayer Business Overview
11.15.3 Bayer Brand Drugs Introduction
11.15.4 Bayer Revenue in Brand Drugs Business (2018-2024)
11.15.5 Bayer Recent Development
11.16 Novo Nordisk
11.16.1 Novo Nordisk Company Detail
11.16.2 Novo Nordisk Business Overview
11.16.3 Novo Nordisk Brand Drugs Introduction
11.16.4 Novo Nordisk Revenue in Brand Drugs Business (2018-2024)
11.16.5 Novo Nordisk Recent Development
11.17 AbbVie
11.17.1 AbbVie Company Detail
11.17.2 AbbVie Business Overview
11.17.3 AbbVie Brand Drugs Introduction
11.17.4 AbbVie Revenue in Brand Drugs Business (2018-2024)
11.17.5 AbbVie Recent Development
11.18 Takeda
11.18.1 Takeda Company Detail
11.18.2 Takeda Business Overview
11.18.3 Takeda Brand Drugs Introduction
11.18.4 Takeda Revenue in Brand Drugs Business (2018-2024)
11.18.5 Takeda Recent Development
11.19 Boehringer Ingelheim
11.19.1 Boehringer Ingelheim Company Detail
11.19.2 Boehringer Ingelheim Business Overview
11.19.3 Boehringer Ingelheim Brand Drugs Introduction
11.19.4 Boehringer Ingelheim Revenue in Brand Drugs Business (2018-2024)
11.19.5 Boehringer Ingelheim Recent Development
11.20 Takeda
11.20.1 Takeda Company Detail
11.20.2 Takeda Business Overview
11.20.3 Takeda Brand Drugs Introduction
11.20.4 Takeda Revenue in Brand Drugs Business (2018-2024)
11.20.5 Takeda Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Brand Drugs Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Biopharmaceutical
Table 3. Key Players of Chemistry Medicine
Table 4. Global Brand Drugs Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Brand Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Brand Drugs Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global Brand Drugs Market Share by Region (2018-2024)
Table 8. Global Brand Drugs Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Brand Drugs Market Share by Region (2024-2029)
Table 10. Brand Drugs Market Trends
Table 11. Brand Drugs Market Drivers
Table 12. Brand Drugs Market Challenges
Table 13. Brand Drugs Market Restraints
Table 14. Global Brand Drugs Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global Brand Drugs Market Share by Players (2018-2024)
Table 16. Global Top Brand Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Brand Drugs as of 2022)
Table 17. Ranking of Global Top Brand Drugs Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Brand Drugs Revenue (CR5 and HHI) & (2018-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Brand Drugs Product Solution and Service
Table 21. Date of Enter into Brand Drugs Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Brand Drugs Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global Brand Drugs Revenue Market Share by Type (2018-2024)
Table 25. Global Brand Drugs Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Brand Drugs Revenue Market Share by Type (2024-2029)
Table 27. Global Brand Drugs Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global Brand Drugs Revenue Market Share by Application (2018-2024)
Table 29. Global Brand Drugs Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Brand Drugs Revenue Market Share by Application (2024-2029)
Table 31. North America Brand Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Brand Drugs Market Size by Country (2018-2024) & (US$ Million)
Table 33. North America Brand Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Brand Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Brand Drugs Market Size by Country (2018-2024) & (US$ Million)
Table 36. Europe Brand Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Brand Drugs Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Brand Drugs Market Size by Region (2018-2024) & (US$ Million)
Table 39. Asia-Pacific Brand Drugs Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Brand Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Brand Drugs Market Size by Country (2018-2024) & (US$ Million)
Table 42. Latin America Brand Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Brand Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Brand Drugs Market Size by Country (2018-2024) & (US$ Million)
Table 45. Middle East & Africa Brand Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 46. Pfizer Company Detail
Table 47. Pfizer Business Overview
Table 48. Pfizer Brand Drugs Product
Table 49. Pfizer Revenue in Brand Drugs Business (2018-2024) & (US$ Million)
Table 50. Pfizer Recent Development
Table 51. Roche Company Detail
Table 52. Roche Business Overview
Table 53. Roche Brand Drugs Product
Table 54. Roche Revenue in Brand Drugs Business (2018-2024) & (US$ Million)
Table 55. Roche Recent Development
Table 56. Sanofi Company Detail
Table 57. Sanofi Business Overview
Table 58. Sanofi Brand Drugs Product
Table 59. Sanofi Revenue in Brand Drugs Business (2018-2024) & (US$ Million)
Table 60. Sanofi Recent Development
Table 61. Johnson & Johnson Company Detail
Table 62. Johnson & Johnson Business Overview
Table 63. Johnson & Johnson Brand Drugs Product
Table 64. Johnson & Johnson Revenue in Brand Drugs Business (2018-2024) & (US$ Million)
Table 65. Johnson & Johnson Recent Development
Table 66. Merck & Co. (MSD) Company Detail
Table 67. Merck & Co. (MSD) Business Overview
Table 68. Merck & Co. (MSD) Brand Drugs Product
Table 69. Merck & Co. (MSD) Revenue in Brand Drugs Business (2018-2024) & (US$ Million)
Table 70. Merck & Co. (MSD) Recent Development
Table 71. Novartis Company Detail
Table 72. Novartis Business Overview
Table 73. Novartis Brand Drugs Product
Table 74. Novartis Revenue in Brand Drugs Business (2018-2024) & (US$ Million)
Table 75. Novartis Recent Development
Table 76. AbbVie Company Detail
Table 77. AbbVie Business Overview
Table 78. AbbVie Brand Drugs Product
Table 79. AbbVie Revenue in Brand Drugs Business (2018-2024) & (US$ Million)
Table 80. AbbVie Recent Development
Table 81. Gilead Sciences Company Detail
Table 82. Gilead Sciences Business Overview
Table 83. Gilead Sciences Brand Drugs Product
Table 84. Gilead Sciences Revenue in Brand Drugs Business (2018-2024) & (US$ Million)
Table 85. Gilead Sciences Recent Development
Table 86. GlaxoSmithKline (GSK) Company Detail
Table 87. GlaxoSmithKline (GSK) Business Overview
Table 88. GlaxoSmithKline (GSK) Brand Drugs Product
Table 89. GlaxoSmithKline (GSK) Revenue in Brand Drugs Business (2018-2024) & (US$ Million)
Table 90. GlaxoSmithKline (GSK) Recent Development
Table 91. Amgen Company Detail
Table 92. Amgen Business Overview
Table 93. Amgen Brand Drugs Product
Table 94. Amgen Revenue in Brand Drugs Business (2018-2024) & (US$ Million)
Table 95. Amgen Recent Development
Table 96. AstraZeneca Company Detail
Table 97. AstraZeneca Business Overview
Table 98. AstraZeneca Brand Drugs Product
Table 99. AstraZeneca Revenue in Brand Drugs Business (2018-2024) & (US$ Million)
Table 100. AstraZeneca Recent Development
Table 101. Bristol-Myers Squibb Company Detail
Table 102. Bristol-Myers Squibb Business Overview
Table 103. Bristol-Myers Squibb Brand Drugs Product
Table 104. Bristol-Myers Squibb Revenue in Brand Drugs Business (2018-2024) & (US$ Million)
Table 105. Bristol-Myers Squibb Recent Development
Table 106. Eli Lilly Company Detail
Table 107. Eli Lilly Business Overview
Table 108. Eli Lilly Brand Drugs Product
Table 109. Eli Lilly Revenue in Brand Drugs Business (2018-2024) & (US$ Million)
Table 110. Eli Lilly Recent Development
Table 111. Teva Company Detail
Table 112. Teva Business Overview
Table 113. Teva Brand Drugs Product
Table 114. Teva Revenue in Brand Drugs Business (2018-2024) & (US$ Million)
Table 115. Teva Recent Development
Table 116. Bayer Company Detail
Table 117. Bayer Business Overview
Table 118. Bayer Brand Drugs Product
Table 119. Bayer Revenue in Brand Drugs Business (2018-2024) & (US$ Million)
Table 120. Bayer Recent Development
Table 121. Novo Nordisk Company Detail
Table 122. Novo Nordisk Business Overview
Table 123. Novo Nordisk Brand Drugs Product
Table 124. Novo Nordisk Revenue in Brand Drugs Business (2018-2024) & (US$ Million)
Table 125. Novo Nordisk Recent Development
Table 126. AbbVie Company Detail
Table 127. AbbVie Business Overview
Table 128. AbbVie Brand Drugs Product
Table 129. AbbVie Revenue in Brand Drugs Business (2018-2024) & (US$ Million)
Table 130. AbbVie Recent Development
Table 131. Takeda Company Detail
Table 132. Takeda Business Overview
Table 133. Takeda Brand Drugs Product
Table 134. Takeda Revenue in Brand Drugs Business (2018-2024) & (US$ Million)
Table 135. Takeda Recent Development
Table 136. Boehringer Ingelheim Company Detail
Table 137. Boehringer Ingelheim Business Overview
Table 138. Boehringer Ingelheim Brand Drugs Product
Table 139. Boehringer Ingelheim Revenue in Brand Drugs Business (2018-2024) & (US$ Million)
Table 140. Boehringer Ingelheim Recent Development
Table 141. Takeda Company Detail
Table 142. Takeda Business Overview
Table 143. Takeda Brand Drugs Product
Table 144. Takeda Revenue in Brand Drugs Business (2018-2024) & (US$ Million)
Table 145. Takeda Recent Development
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Brand Drugs Market Size Comparison by Type (2024-2029) & (US$ Million)
Figure 2. Global Brand Drugs Market Share by Type: 2022 VS 2029
Figure 3. Biopharmaceutical Features
Figure 4. Chemistry Medicine Features
Figure 5. Global Brand Drugs Market Size Comparison by Application (2024-2029) & (US$ Million)
Figure 6. Global Brand Drugs Market Share by Application: 2022 VS 2029
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Other Case Studies
Figure 10. Brand Drugs Report Years Considered
Figure 11. Global Brand Drugs Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Brand Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Brand Drugs Market Share by Region: 2022 VS 2029
Figure 14. Global Brand Drugs Market Share by Players in 2022
Figure 15. Global Top Brand Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Brand Drugs as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Brand Drugs Revenue in 2022
Figure 17. North America Brand Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Brand Drugs Market Share by Country (2018-2029)
Figure 19. United States Brand Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Canada Brand Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Brand Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Brand Drugs Market Share by Country (2018-2029)
Figure 23. Germany Brand Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. France Brand Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. U.K. Brand Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Italy Brand Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Russia Brand Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Nordic Countries Brand Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Brand Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Brand Drugs Market Share by Region (2018-2029)
Figure 31. China Brand Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Japan Brand Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. South Korea Brand Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Southeast Asia Brand Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. India Brand Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Australia Brand Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Brand Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Brand Drugs Market Share by Country (2018-2029)
Figure 39. Mexico Brand Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Brazil Brand Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Brand Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Brand Drugs Market Share by Country (2018-2029)
Figure 43. Turkey Brand Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Saudi Arabia Brand Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Pfizer Revenue Growth Rate in Brand Drugs Business (2018-2024)
Figure 46. Roche Revenue Growth Rate in Brand Drugs Business (2018-2024)
Figure 47. Sanofi Revenue Growth Rate in Brand Drugs Business (2018-2024)
Figure 48. Johnson & Johnson Revenue Growth Rate in Brand Drugs Business (2018-2024)
Figure 49. Merck & Co. (MSD) Revenue Growth Rate in Brand Drugs Business (2018-2024)
Figure 50. Novartis Revenue Growth Rate in Brand Drugs Business (2018-2024)
Figure 51. AbbVie Revenue Growth Rate in Brand Drugs Business (2018-2024)
Figure 52. Gilead Sciences Revenue Growth Rate in Brand Drugs Business (2018-2024)
Figure 53. GlaxoSmithKline (GSK) Revenue Growth Rate in Brand Drugs Business (2018-2024)
Figure 54. Amgen Revenue Growth Rate in Brand Drugs Business (2018-2024)
Figure 55. AstraZeneca Revenue Growth Rate in Brand Drugs Business (2018-2024)
Figure 56. Bristol-Myers Squibb Revenue Growth Rate in Brand Drugs Business (2018-2024)
Figure 57. Eli Lilly Revenue Growth Rate in Brand Drugs Business (2018-2024)
Figure 58. Teva Revenue Growth Rate in Brand Drugs Business (2018-2024)
Figure 59. Bayer Revenue Growth Rate in Brand Drugs Business (2018-2024)
Figure 60. Novo Nordisk Revenue Growth Rate in Brand Drugs Business (2018-2024)
Figure 61. AbbVie Revenue Growth Rate in Brand Drugs Business (2018-2024)
Figure 62. Takeda Revenue Growth Rate in Brand Drugs Business (2018-2024)
Figure 63. Boehringer Ingelheim Revenue Growth Rate in Brand Drugs Business (2018-2024)
Figure 64. Takeda Revenue Growth Rate in Brand Drugs Business (2018-2024)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries